Isomab makes two key appointments; Dr Shi Yin Foo as Non-Executive Director and Dr Gary Burgess as CMO
Dr Shi Yin Foo is the scientific founder and CEO of Arvada Therapeutics. She is a cardiologist and immunologist with over 20 years of experience as a practicing physician and a catalyst in advancing innovative new programs through various stages of drug development. She has been in executive roles at multiple biotechnology companies, including Novartis […]